Diatherix Revenue and Competitors
Estimated Revenue & Valuation
- Diatherix's estimated annual revenue is currently $28.4M per year.
- Diatherix's estimated revenue per employee is $155,000
Employee Data
- Diatherix has 183 Employees.
- Diatherix grew their employee count by -11% last year.
Diatherix's People
Name | Title | Email/Phone |
---|---|---|
1 | Project Manager | Reveal Email/Phone |
Diatherix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $67.3M | 434 | 66% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $2.6M | 17 | 0% | N/A | N/A |
#4 | $1.7M | 11 | 10% | N/A | N/A |
#5 | $17.1M | 110 | -3% | N/A | N/A |
#6 | $3.3M | 21 | 950% | N/A | N/A |
#7 | $2.6M | 17 | 6% | N/A | N/A |
#8 | $1.6M | 10 | 0% | N/A | N/A |
#9 | $4.2M | 27 | 23% | N/A | N/A |
#10 | $28.4M | 183 | -11% | N/A | N/A |
What Is Diatherix?
A unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary TEM-PCRᅢᄁ¬ダᅡᄁ. Diatherix Eurofins distinctions: - Delivers one-day results - Identifies bacteria regardless of recent antibiotic use - Offers simplicity of single-sample collection - Identifies difficult-to-culture pathogens - Yields a high level of sensitivity and specificity
keywords:N/AN/A
Total Funding
183
Number of Employees
$28.4M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diatherix News
Diatherix Laboratories, Gen-Probe, Qiagen, F. Hoffmann-La Roche, Cepheid, Life Technologies Corporation, Meridian Biosciences,...
... F.Hoffmann-La Roche, Hain Lifescience, Biomerieux, 3M, Bio-Rad Laboratories, Abacus Diagnostica, Abbott, Puritan Medical, Diatherix.
Previously he served as the Chief Scientific Officer and Clinical Laboratory Director for Diatherix-Eurofins, in Huntsville, Alabama.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $29.3M | 184 | 34% | N/A |
#2 | $63.4M | 187 | 10% | N/A |
#3 | $63.7M | 188 | -6% | N/A |
#4 | $37.4M | 189 | 31% | N/A |
#5 | $28.7M | 191 | -7% | N/A |